Dietrich A. Stephan, President and CEO, 10% Owner at NeuBase Therapeutics, Inc. (NBSE), bought 10,000 shares at $6.00 ($60K) on 2020-04-30, disclosed to the SEC on 2020-05-04.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.